In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis being a Program III drug. This rescheduling will acknowledge that cannabis has legitimate healthcare purposes and might help open the door to study on other likely procedure uses. Smoking c